New Medicine Service (NMS)

The New Medicine Service (NMS) was the fourth Advanced Service to be added to the Community Pharmacy Contractual Framework (CPCF); it commenced on 1 October 2011.

The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is focused on specific patient groups and conditions.

Forthcoming changes to the service

Developments in NMS IT support planned for December 2023

From a date to be determined, subject to positive evaluation of an ongoing pilot, the NMS will expand to include antidepressants to enable patients who are newly prescribed an antidepressant to receive extra support from their community pharmacist.

Further details on this change will be published on the CPE website in due course.

For more information visit the Community Pharmacy England website New Medicine Service (NMS).